MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3899/jrheum.120205

Медицинская библиотека · The Journal of rheumatology · 2012

Pulmonary hemorrhage in antiphospholipid antibody syndrome.

Scheiman Elazary Anat, Cohen Matan J, Aamar Suhail, Dranitzki Zvi, Tayer-Shifman Oshrat, Mevorach Dror, Ben-Chetrit Eldad, Naparstek Yaakov

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To characterize the clinical manifestations of patients with antiphospholipid antibody syndrome (APS) and pulmonary hemorrhage (PH).

METHODS

We performed a retrospective, single-center analysis of patients with APS who were followed up from 1980 to 2011. Of these patients, only those who fulfilled the Sydney criteria for APS were included. Patients with APS that manifested with PH were called the PHAPS group. The rest of the patients with APS served as controls. Clinical manifestations were compared between the PHAPS group and controls.

RESULTS

Sixty-three patients fulfilled the criteria for APS. Thirteen experienced PH and were included in the PHAPS group. Seventy-five percent of the patients with PHAPS and 22% of the controls had mitral valve disease (p = 0.001). Central nervous system (CNS) involvement (cerebrovascular accident, seizures) was present in 61% and 16% of the patients with PHAPS and controls, respectively (p = 0.001). Skin involvement (livedo reticularis, chronic leg ulcers) was present in 54% and 8% of the patients with PHAPS and controls (p = 0.001). Pregnancy morbidity occurred in 87.5% and 32.5% of the patients with PHAPS and controls (p = 0.005). Ninety-two percent and 83% of the patients with PHAPS had high-titer immunoglobulin γ (IgG) anticardiolipin and β(2)-glycoprotein I IgG antibodies compared to 43% and 30% of the controls (p = 0.002, p < 0.001, respectively).

CONCLUSION

Patients with PHAPS were more likely than controls to have mitral valve disease, skin disease, CNS involvement, and pregnancy morbidity as well as high-titer APS. PHAPS seems to be a unique subgroup of all patients with APS.

Для цитирования: Scheiman Elazary Anat, Cohen Matan J, Aamar Suhail, Dranitzki Zvi, Tayer-Shifman Oshrat, Mevorach Dror, Ben-Chetrit Eldad, Naparstek Yaakov. Pulmonary hemorrhage in antiphospholipid antibody syndrome.. The Journal of rheumatology. 2012. DOI: 10.3899/jrheum.120205.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.